Cargando…
Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy
The field of HIV prevention has indeed progressed in leaps and bounds, but with major limitations of the current prevention and treatment options, the world remains desperate for an HIV vaccine. Sadly, this continues to be elusive, because more than 30 years since its discovery there is no licensed...
Autores principales: | Chanzu, Nadia, Ondondo, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021115/ https://www.ncbi.nlm.nih.gov/pubmed/24847327 http://dx.doi.org/10.3389/fimmu.2014.00202 |
Ejemplares similares
-
Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection
por: Zhu, Qing, et al.
Publicado: (2012) -
The influence of delivery vectors on HIV vaccine efficacy
por: Ondondo, Beatrice O.
Publicado: (2014) -
Fallen Angels or Risen Apes? A Tale of the Intricate Complexities of Imbalanced Immune Responses in the Pathogenesis and Progression of Immune-Mediated and Viral Cancers
por: Ondondo, Beatrice Omusiro
Publicado: (2014) -
Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018) -
Home Sweet Home: The Tumor Microenvironment as a Haven for Regulatory T Cells
por: Ondondo, Beatrice, et al.
Publicado: (2013)